Azeria Therapeutics is the world’s first pioneer factor drug discovery company.
Azeria Therapeutics has raised €36M across 1 funding round from 1 investor, most recently a Series B round in Oct 2019. Based in Cambridge, UK; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-10-01 | Series B |
| €36M |
| Syncona Partners LLP |
| View deal → |
